View in EDS

Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City.

Saved in:
Bibliographic Details
Title: Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City.
Authors: Saxena A; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Engel AJ; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Banbury B; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Hasan G; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Fraser N; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Zaminski D; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Masson M; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Haberman RH; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Scher JU; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Ho G; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Law J; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Rackoff P; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Tseng CE; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Belmont HM; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Clancy RM; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Buyon JP; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA., Izmirly PM; Division of Rheumatology, Department of Medicine, New York University Grossman School of Medicine, New York, NY 10016, USA.
Source: The Lancet. Rheumatology [Lancet Rheumatol] 2022 Sep; Vol. 4 (9), pp. e582-e585. Date of Electronic Publication: 2022 Jul 12.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 101765308 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2665-9913 (Electronic) Linking ISSN: 26659913 NLM ISO Abbreviation: Lancet Rheumatol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2665-9913
DOI:10.1016/S2665-9913(22)00190-4